BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30269770)

  • 21. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma.
    Czapiewski P; Bobowicz M; Pęksa R; Skrzypski M; Gorczyński A; Szczepańska-Michalska K; Korwat A; Jankowski M; Zegarski W; Szulgo-Paczkowska A; Polec T; Piątek M; Skokowski J; Haybaeck J; Żaczek A; Biernat W
    Pol J Pathol; 2016; 67(3):228-234. PubMed ID: 28155971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1 and MUC5AC implication in Tunisian colorectal cancer patients.
    Hazgui M; Weslati M; Boughriba R; Ounissi D; Bacha D; Bouraoui S
    Turk J Med Sci; 2021 Feb; 51(1):309-318. PubMed ID: 32967412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.
    Nakamori S; Ota DM; Cleary KR; Shirotani K; Irimura T
    Gastroenterology; 1994 Feb; 106(2):353-61. PubMed ID: 7905449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study.
    Broll R; Schauer V; Schimmelpenning H; Strik M; Woltmann A; Best R; Bruch HP; Duchrow M
    Dis Colon Rectum; 1997 Dec; 40(12):1465-71. PubMed ID: 9407986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.
    Guo Q; Tang W; Inagaki Y; Midorikawa Y; Kokudo N; Sugawara Y; Nakata M; Konishi T; Nagawa H; Makuuchi M
    World J Gastroenterol; 2006 Jan; 12(1):54-9. PubMed ID: 16440417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Miyahara N; Suzuki H; Furukawa M; Todoroki T; Tanaka N; Irimura T
    Clin Exp Metastasis; 2004; 21(4):353-62. PubMed ID: 15554392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of mucin expression profiles in breast carcinoma with signet ring cells: a clinicopathological study.
    Ohashi R; Hayama A; Yanagihara K; Yamashita K; Sakatani T; Takei H; Naito Z
    Diagn Pathol; 2016 Nov; 11(1):131. PubMed ID: 27846863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence.
    Ohgami A; Tsuda T; Osaki T; Mitsudomi T; Morimoto Y; Higashi T; Yasumoto K
    Ann Thorac Surg; 1999 Mar; 67(3):810-4. PubMed ID: 10215233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor.
    Genitsch V; Zlobec I; Thalmann GN; Fleischmann A
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):242-7. PubMed ID: 27165976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
    Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
    Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases.
    Murakami T; Yao T; Yatagai N; Yamashiro Y; Saito T; Sakamoto N; Nagahara A
    Histopathology; 2020 Jan; 76(2):325-332. PubMed ID: 31429980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
    Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
    Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.
    Nakamori S; Watanabe H; Kameyama M; Imaoka S; Furukawa H; Ishikawa O; Sasaki Y; Kabuto T; Raz A
    Cancer; 1994 Oct; 74(7):1855-62. PubMed ID: 8082090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
    Suzuki H; Shoda J; Kawamoto T; Shinozaki E; Miyahara N; Hotta S; Iizuka Y; Nakahara A; Tanaka N; Yanaka A; Irimura T
    Clin Exp Metastasis; 2004; 21(4):321-9. PubMed ID: 15554388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis.
    Kashiwagi H; Kijima H; Dowaki S; Ohtani Y; Tobita K; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
    Oncol Rep; 2001; 8(3):485-9. PubMed ID: 11295067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced E-cadherin expression and enlargement of cancer nuclei strongly correlate with hematogenic metastasis in colorectal adenocarcinoma.
    Ikeguchi M; Taniguchi T; Makino M; Kaibara N
    Scand J Gastroenterol; 2000 Aug; 35(8):839-46. PubMed ID: 10994623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence.
    Sato K; Mori R; Hiroshima Y; Oba MS; Matsuyama R; Bouvet M; Hoffman RM; Endo I
    J Surg Res; 2018 Jun; 226():122-130. PubMed ID: 29661277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
    Han D; Wei Y; Wang X; Wang G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.